DGM
Darwin Global Management Portfolio holdings
AUM
$2.38B
This Quarter Return
+25.89%
1 Year Return
+81.43%
3 Year Return
+6,053.69%
5 Year Return
–
10 Year Return
–
AUM
$161M
AUM Growth
+$161M
(+142%)
Cap. Flow
+$94.2M
Cap. Flow
% of AUM
58.66%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
4
Increased
–
Reduced
–
Closed
2
Top Buys
| 1 |
argenx
ARGX
|
$113M |
| 2 |
Keros Therapeutics
KROS
|
$20.6M |
| 3 |
AMAM
Ambrx Biopharma, Inc. Common Stock
AMAM
|
$17.2M |
| 4 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$10.1M |
Top Sells
| 1 |
Ventyx Biosciences
VTYX
|
$48.9M |
| 2 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$17.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
argenx
ARGX
$43.6B
| $113M | 70.21% | +297,701 | New | +$113M |
|
|
2
Keros Therapeutics
KROS
$618M
| $20.6M | 12.81% | +428,532 | New | +$20.6M |
|
|
AMAM
3
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| $17.2M | 10.72% | +7,584,489 | New | +$17.2M |
|
|
RXDX
4
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $10.1M | 6.26% | +91,379 | New | +$10.1M |
|
|
5
Ventyx Biosciences
VTYX
$171M
| – | – | -1,401,123 | Closed | -$48.9M |
|
|
KRTX
6
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| – | – | -77,768 | Closed | -$17.5M |
|